CURRENT REPORT

Company

ABVC BIOPHARMA, INC.

Filed

May 23, 2024

Period of Report

May 23, 2024

Accession Number

0001213900-24-046313

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →